Point‐of‐care anti‐BCMA CAR T‐cell therapy induces encouraging response rates in high‐risk relapsed/refractory multiple myeloma Meeting Abstract


Authors: Magen, H.; Fried, S.; Itzhaki, O.; Shem‐Tov, N.; Danylesko, I.; Yerushalmi, R.; Marcus, R.; Shouval, R.; Nevo, L.; Shapira‐Frommer, R.; Nagler, A.; Shimoni, A.; Shkury, E.; Avigdor, A.
Abstract Title: Point‐of‐care anti‐BCMA CAR T‐cell therapy induces encouraging response rates in high‐risk relapsed/refractory multiple myeloma
Meeting Title: 17th International Conference on Malignant Lymphoma (ICML)
Journal Title: Hematological Oncology
Volume: 41
Issue: Suppl. 2
Meeting Dates: 2023 Jun 13-17
Meeting Location: Lugano, Switzerland
ISSN: 0278-0232
Publisher: Wiley Blackwell  
Date Published: 2023-06-01
Start Page: 82
End Page: 83
Language: English
DOI: 10.1002/hon.3163_46
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting Abstract: 046 -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Roni Shouval
    167 Shouval